findmyKOL
Clinical trialNCT01533389CompletedPhase 4Interventional

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

SponsorJW PharmaceuticalEnrollment114Ureteral Stone
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

South Korea
  • Myongji Hospital

    Goyang-si, Gyonggi-Do, South Korea

  • Nhic Ilsan Hospital

    Goyang-si, Gyonggi-Do, South Korea

  • Eulji General Hospital

    Seoul, Seoul, South Korea

  • Inje Univ. Sanggye Paik Hospital

    Seoul, Seoul, South Korea

  • Kangbuk Samsung Medical Center

    Seoul, Seoul, South Korea

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Oct 2011
Primary completion
31 Mar 2012
Completion
31 Aug 2012
Last update posted
20 Nov 2013
Registered enrollment
114
Registry id
NCT01533389
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.